Skip navigation

Items where Author is "Akanda, Md Mushfiq"

Items where Author is "Akanda, Md Mushfiq"

Up a level
Export as [feed] RSS
Group by: Item Type | Uncontrolled Keywords | No Grouping
bioconjugation curcumin prostate cancer solid lipid nanoparticles transferrin
Number of items: 5.

bioconjugation

Akanda, Md Mushfiq, Getti, Giulia ORCID: 0000-0003-1402-8496 , Nandi, Uttom, Mithu, Md Sadeque Hossain and Douroumis, Dionysios ORCID: 0000-0002-3782-0091 (2021) Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy. International Journal of Pharmaceutics, 599:120416. ISSN 0378-5173 (doi:https://doi.org/10.1016/j.ijpharm.2021.120416)

curcumin

Akanda, Md Mushfiq, Getti, Giulia ORCID: 0000-0003-1402-8496 , Nandi, Uttom, Mithu, Md Sadeque Hossain and Douroumis, Dionysios ORCID: 0000-0002-3782-0091 (2021) Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy. International Journal of Pharmaceutics, 599:120416. ISSN 0378-5173 (doi:https://doi.org/10.1016/j.ijpharm.2021.120416)

prostate cancer

Akanda, Md Mushfiq, Getti, Giulia ORCID: 0000-0003-1402-8496 , Nandi, Uttom, Mithu, Md Sadeque Hossain and Douroumis, Dionysios ORCID: 0000-0002-3782-0091 (2021) Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy. International Journal of Pharmaceutics, 599:120416. ISSN 0378-5173 (doi:https://doi.org/10.1016/j.ijpharm.2021.120416)

solid lipid nanoparticles

Akanda, Md Mushfiq, Getti, Giulia ORCID: 0000-0003-1402-8496 , Nandi, Uttom, Mithu, Md Sadeque Hossain and Douroumis, Dionysios ORCID: 0000-0002-3782-0091 (2021) Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy. International Journal of Pharmaceutics, 599:120416. ISSN 0378-5173 (doi:https://doi.org/10.1016/j.ijpharm.2021.120416)

transferrin

Akanda, Md Mushfiq, Getti, Giulia ORCID: 0000-0003-1402-8496 , Nandi, Uttom, Mithu, Md Sadeque Hossain and Douroumis, Dionysios ORCID: 0000-0002-3782-0091 (2021) Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy. International Journal of Pharmaceutics, 599:120416. ISSN 0378-5173 (doi:https://doi.org/10.1016/j.ijpharm.2021.120416)

This list was generated on Thu Nov 21 20:55:14 2024 UTC.